Cargando…
The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer
Macroautophagy/autophagy is a cellular process to recycle damaged cellular components, and its modulation can be exploited for disease treatments. A key autophagy player is the ubiquitin-like protein MAP1LC3B/LC3B. Mutations and changes in MAP1LC3B expression occur in cancer samples. However, the in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525936/ https://www.ncbi.nlm.nih.gov/pubmed/33302793 http://dx.doi.org/10.1080/15548627.2020.1847443 |
_version_ | 1784585781676867584 |
---|---|
author | Fas, Burcu Aykac Maiani, Emiliano Sora, Valentina Kumar, Mukesh Mashkoor, Maliha Lambrughi, Matteo Tiberti, Matteo Papaleo, Elena |
author_facet | Fas, Burcu Aykac Maiani, Emiliano Sora, Valentina Kumar, Mukesh Mashkoor, Maliha Lambrughi, Matteo Tiberti, Matteo Papaleo, Elena |
author_sort | Fas, Burcu Aykac |
collection | PubMed |
description | Macroautophagy/autophagy is a cellular process to recycle damaged cellular components, and its modulation can be exploited for disease treatments. A key autophagy player is the ubiquitin-like protein MAP1LC3B/LC3B. Mutations and changes in MAP1LC3B expression occur in cancer samples. However, the investigation of the effects of these mutations on MAP1LC3B protein structure is still missing. Despite many LC3B structures that have been solved, a comprehensive study, including dynamics, has not yet been undertaken. To address this knowledge gap, we assessed nine physical models for biomolecular simulations for their capabilities to describe the structural ensemble of MAP1LC3B. With the resulting MAP1LC3B structural ensembles, we characterized the impact of 26 missense mutations from pan-cancer studies with different approaches, and we experimentally validated our prediction for six variants using cellular assays. Our findings shed light on damaging or neutral mutations in MAP1LC3B, providing an atlas of its modifications in cancer. In particular, P32Q mutation was found detrimental for protein stability with a propensity to aggregation. In a broader context, our framework can be applied to assess the pathogenicity of protein mutations or to prioritize variants for experimental studies, allowing to comprehensively account for different aspects that mutational events alter in terms of protein structure and function. Abbreviations: ATG: autophagy-related; Cα: alpha carbon; CG: coarse-grained; CHARMM: Chemistry at Harvard macromolecular mechanics; CONAN: contact analysis; FUNDC1: FUN14 domain containing 1; FYCO1: FYVE and coiled-coil domain containing 1; GABARAP: GABA type A receptor-associated protein; GROMACS: Groningen machine for chemical simulations; HP: hydrophobic pocket; LIR: LC3 interacting region; MAP1LC3B/LC3B microtubule associated protein 1 light chain 3 B; MD: molecular dynamics; OPTN: optineurin; OSF: open software foundation; PE: phosphatidylethanolamine, PLEKHM1: pleckstrin homology domain-containing family M 1; PSN: protein structure network; PTM: post-translational modification; SA: structural alphabet; SLiM: short linear motif; SQSTM1/p62: sequestosome 1; WT: wild-type. |
format | Online Article Text |
id | pubmed-8525936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-85259362021-10-20 The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer Fas, Burcu Aykac Maiani, Emiliano Sora, Valentina Kumar, Mukesh Mashkoor, Maliha Lambrughi, Matteo Tiberti, Matteo Papaleo, Elena Autophagy Research Paper Macroautophagy/autophagy is a cellular process to recycle damaged cellular components, and its modulation can be exploited for disease treatments. A key autophagy player is the ubiquitin-like protein MAP1LC3B/LC3B. Mutations and changes in MAP1LC3B expression occur in cancer samples. However, the investigation of the effects of these mutations on MAP1LC3B protein structure is still missing. Despite many LC3B structures that have been solved, a comprehensive study, including dynamics, has not yet been undertaken. To address this knowledge gap, we assessed nine physical models for biomolecular simulations for their capabilities to describe the structural ensemble of MAP1LC3B. With the resulting MAP1LC3B structural ensembles, we characterized the impact of 26 missense mutations from pan-cancer studies with different approaches, and we experimentally validated our prediction for six variants using cellular assays. Our findings shed light on damaging or neutral mutations in MAP1LC3B, providing an atlas of its modifications in cancer. In particular, P32Q mutation was found detrimental for protein stability with a propensity to aggregation. In a broader context, our framework can be applied to assess the pathogenicity of protein mutations or to prioritize variants for experimental studies, allowing to comprehensively account for different aspects that mutational events alter in terms of protein structure and function. Abbreviations: ATG: autophagy-related; Cα: alpha carbon; CG: coarse-grained; CHARMM: Chemistry at Harvard macromolecular mechanics; CONAN: contact analysis; FUNDC1: FUN14 domain containing 1; FYCO1: FYVE and coiled-coil domain containing 1; GABARAP: GABA type A receptor-associated protein; GROMACS: Groningen machine for chemical simulations; HP: hydrophobic pocket; LIR: LC3 interacting region; MAP1LC3B/LC3B microtubule associated protein 1 light chain 3 B; MD: molecular dynamics; OPTN: optineurin; OSF: open software foundation; PE: phosphatidylethanolamine, PLEKHM1: pleckstrin homology domain-containing family M 1; PSN: protein structure network; PTM: post-translational modification; SA: structural alphabet; SLiM: short linear motif; SQSTM1/p62: sequestosome 1; WT: wild-type. Taylor & Francis 2020-12-11 /pmc/articles/PMC8525936/ /pubmed/33302793 http://dx.doi.org/10.1080/15548627.2020.1847443 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Research Paper Fas, Burcu Aykac Maiani, Emiliano Sora, Valentina Kumar, Mukesh Mashkoor, Maliha Lambrughi, Matteo Tiberti, Matteo Papaleo, Elena The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer |
title | The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer |
title_full | The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer |
title_fullStr | The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer |
title_full_unstemmed | The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer |
title_short | The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer |
title_sort | conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525936/ https://www.ncbi.nlm.nih.gov/pubmed/33302793 http://dx.doi.org/10.1080/15548627.2020.1847443 |
work_keys_str_mv | AT fasburcuaykac theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT maianiemiliano theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT soravalentina theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT kumarmukesh theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT mashkoormaliha theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT lambrughimatteo theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT tibertimatteo theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT papaleoelena theconformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT fasburcuaykac conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT maianiemiliano conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT soravalentina conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT kumarmukesh conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT mashkoormaliha conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT lambrughimatteo conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT tibertimatteo conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer AT papaleoelena conformationalandmutationallandscapeoftheubiquitinlikemarkerforautophagosomeformationincancer |